US Stem Cell Inc
OTC:USRM
US Stem Cell Inc
OTC:USRM
Price:
0.0001
USD
Market Closed
Market Cap:
$642
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
US Stem Cell Inc
OTC:USRM
|
US |
|
P
|
Purefun Group AB (publ)
F:DU3
|
SE |
|
S
|
Singer Thailand PCL
SET:SINGER
|
TH |
|
A
|
Areeya Property PCL
SET:A
|
TH |
|
Odfjell SE
F:O7F
|
NO |
|
Dataproces Group A/S
CSE:DATA
|
DK |
|
P
|
Practical Solution PCL
SET:TPS
|
TH |
|
Sietel Ltd
ASX:SSL
|
AU |
|
Aryzta AG
SIX:ARYN
|
CH |
|
Banyan Tree Holdings Ltd
F:1O7
|
SG |
|
N
|
Nirvana Daii PCL
SET:NVD
|
TH |
|
Nizhnekamskshina PAO
MOEX:NKSH
|
RU |
Intrinsic Value
Not Available for USRM
There is not enough data to reliably calculate the intrinsic value for US Stem Cell Inc.
Do our valuations actually work? See backtest results .
Alternatives to USRM
Fundamental Analysis
What US Stem Cell Does
U.S.Stem Cell, Inc. is a biotechnology company, which engages in the discovery, development, and subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage. Stem Cell, Inc. is a biotechnology company. The firm is focused on the discovery, development and subject to regulatory approval and commercialization of autologous cell therapies for the treatment of chronic and acute heart damage.
- Headquarters
- United States of America US
- IPO date
- Feb 19, 2008
Financials
Revenue & Expenses Breakdown
US Stem Cell Inc
US Stem Cell Inc
Efficiency
Earnings Waterfall
US Stem Cell Inc
US Stem Cell Inc
